申请人:Melinta Therapeutics, Inc.
公开号:US10259825B2
公开(公告)日:2019-04-16
The present invention relates generally to the field of antimicrobial compounds and to methods of making and using them. These compounds are useful for treating, preventing, and/or reducing the risk of microbial infections in humans and animals.
本发明总体上涉及抗微生物化合物领域及其制造和使用方法。这些化合物可用于治疗、预防和/或降低人类和动物微生物感染的风险。